Idaho Medicaid to be privately managed in 2029, health officials officials expect
Idaho health officials say it'll take years to switch all Idaho Medicaid benefits to being managed by private companies.
Through a sweeping bill meant to cut Medicaid costs, the Idaho Legislature this year directed the Idaho Department of Health and Welfare to change a range of Medicaid policies — including to pursue switching Medicaid benefits to being run by private companies.
That model, called managed care, is used widely across the country.
Right now, Idaho Medicaid already uses managed care — somewhat. But it's more of a patchwork approach, where some services are managed by the state health department, some by managed care organizations, and some by doctors' offices.
Shifting Idaho Medicaid to managed care will take time to do well, Idaho Medicaid Deputy Director Juliet Charron told a panel of state lawmakers late last month.
The Idaho Department of Health and Welfare expects the new comprehensive Idaho Medicaid managed care contract to start in 2029, following years of prep work, she told the Idaho Legislature's Medicaid Review Panel on May 22.
'We have been evaluating all of the different scenarios and timelines under which we could implement this — looking at it as early as 2027 or 2028 — and have determined' that going much earlier is risky, Charron said. 'Because you're going to start to have pieces overlapping throughout this. And that will be particularly challenging for our provider communities.'
Medicaid is a largely federally funded health care assistance program that covers about 260,000 Idahoans, including low-income earners, people with disabilities, pregnant women, and some older people. Roughly 92,000 Idahoans are enrolled in Medicaid expansion, a voter-approved policy that raised the income eligibility cap.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Idaho governor signs bill to privatize management, add work requirements to Medicaid program
The new Idaho Medicaid cost cutting bill also called for Idaho to seek federal approval for Medicaid work requirements for able-bodied adults. The Idaho Department of Health and Welfare plans to apply for that by July 2026.
The federal spending and tax cut bill being considered by Congress might ease the process for Idaho to seek Medicaid work requirements.
Instead of applying for a Medicaid waiver that could temporarily allow for work requirements, Idaho could seek a longer-lasting state plan amendment for Medicaid work requirements — if the federal bill becomes law, Charron said. (The bill would require nationwide Medicaid work requirements years later. After passing the U.S. House, it heads to the Senate, where changes are expected.)
Other states' experiences and a federal watchdog report suggest costs for Medicaid work requirements are high, the Idaho Capital Sun previously reported.
Since almost half of Idahoans on Medicaid are already working, some advocates say work requirements are effectively just expensive administrative barriers to access the program.
Overall, only 6% of Idaho Medicaid enrollees are in comprehensive managed care — the roughly 27,000 Idahoans dually eligible for Medicare and Medicaid, Idaho Idaho Medicaid Deputy Administrator Sasha O'Connell told the legislative panel.
CONTACT US
Idaho's existing Medicaid managed care contracts mostly carve out private management for certain benefits, like mental health, medical transportation and dental.
That split makes it complicated for the state to oversee, O'Connell said.
'What this has led to is we have particularly high turnover, I would say, in state agencies. And I think that that happens in Medicaid as well,' she said.
The various contracts have put Idaho Medicaid's limited staff in a cycle of 'amending these contracts constantly,' she said, instead of putting the contracts up for a new competitive bid, a process called procurement.
'Because procurement is such a huge lift,' O'Connell said.
Idaho is also on track to end doctors' offices managing Medicaid benefits next year, Charron told lawmakers. The new Idaho Medicaid cost cutting bill called for the end of that model, called value-based care, which is unique to Idaho and has existed for a few years.
The new Idaho Medicaid managed care contract is likely to become the biggest contract given out by the state of Idaho.
Idaho's contract for the company Magellan to run mental health Medicaid benefits is already the state's largest contract, initially pegged at $1.4 billion over four years.
Like under Idaho Medicaid's first managed care mental health organization, Idaho Medicaid providers have reported payment delays from Magellan, the Idaho Capital Sun reported.
Sen. Kevin Cook, R-Idaho Falls, raised that issue to Idaho health officials.
'You're saying, I'm getting reports back from the (managed care organization), and they're saying, 'Everything is great. All of our providers are happy. They're loving it,'' Cook said. ''That's like asking the fox, … 'How's the hen house?''
Idaho's existing managed care contracts will be phased out for the broader contract to come.
Idaho Medicaid mental health contractor hires three state government employees
'Idaho is a very large state. But our health care infrastructure is somewhat limited. And people access health care all over the state. Frequently, we are sending Medicaid participants to different parts of the state, based on the service that they need,' Charron said.
The new contract will task three different managed care organizations to run Idaho Medicaid benefits, for a few reasons, she explained, like:
Federal requirements for Medicaid enrollees to have choice under managed care;
Creating competition between companies to drive efficiencies; and
Redundancy, in case a plan terminates.
Before Idaho launches the new managed care contract, Idaho has a lot of preparation to do, state health officials say. Like engaging stakeholders, seeking out more information and contracting out for actuarial services, a pharmacy benefits manager (PBM), a new enrollment broker for Medicaid enrollees to pick managed care plans, and Idaho Medicaid's information system.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gizmodo
13 minutes ago
- Gizmodo
Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs
The federal government may not have closed the window on paying for GLP-1 weight loss drugs like Ozempic and Zepbound after all. The Trump administration is reportedly planning to conduct an experiment that will allow some people to have obesity drugs covered by their Medicaid and Medicare plans. The Washington Post first broke the news Friday morning, having reportedly obtained documents from the Centers for Medicare and Medicaid Services outlining the plan. It would enable state Medicaid programs and Medicare Part D insurance plans to cover people's medications explicitly meant for 'weight management,' starting next year. Should the experiment go well, it could pave the way to widespread Medicare and Medicaid coverage of these expensive but effective drugs. A Staggering Number of U.S. Adults Are Eligible for Ozempic, Study Finds As things stand now, Medicare cannot directly cover any medications for treating obesity, including newer GLP-1 agents like semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). Programs do have some leeway in providing coverage to people taking Ozempic and similar drugs for diabetes or certain obesity-related conditions, such as heart disease. Last year, the Biden administration proposed a rule designed to end this restriction, opening up coverage to some 7 million Americans on Medicare and Medicaid by 2026. In April this year, though, the Trump administration dropped the proposed rule entirely. However, Health Secretary Robert F. Kennedy Jr., who's previously criticized Ozempic in the past, did state at the time that the White House was still considering a 'framework' to expand coverage. Trump Is Promising to Lower Drug Prices. Don't Count on It According to the Washington Post, the Center for Medicare and Medicaid Innovation—an organization tasked with finding ways to lower health care costs and improve patient care—will be in charge of the experiment. Some specifics of the plan, including the exact criteria for eligibility, may still be up in the air, since the government could provide a window for public comment and further modification if it so chooses. As currently outlined, though, the experiment is expected to run for at least five years. Medicaid programs would reportedly be able to offer coverage starting in April 2026, while Medicare plans could do so in January 2027. The newest GLP-1 drugs like semaglutide have proven to be much more effective at helping people lose weight than diet and exercise alone. But their high costs and limited insurance coverage have impeded many people from obtaining or staying on these treatments long-term (some users are also unable to tolerate the common gastrointestinal side effects they cause). That said, this proposed plan is the latest sign that these cost issues are improving. The list prices of Ozempic and similar drugs have started to drop as of late; for instance, America's upstairs neighbor Canada is expected to approve the first generics of Ozempic early next year (that probably won't happen until 2030 in the U.S., though). The likely arrival of new approved competitors to these drugs as early as next year is also expected to drive down prices in general.


New York Times
44 minutes ago
- New York Times
A Catalog of Losses Under Trump
To the Editor: Re 'This Is Why America Needs Public Media' (editorial, July 20): Rural supporters of President Trump across the country are now likely to lose public media upon which they rely. They are also threatened with the loss of Medicaid and Affordable Care Act benefits; the shuttering of rural hospitals; the arrest and deportation of respected community members; a shortage of farm workers at harvest time; a tariff-driven rise in prices of food, clothing and other essentials, combined with problems marketing produce overseas; the dismantling of effective warning systems for tornadoes, hurricanes, floods and wildfires; and a weakened FEMA response to the subsequent devastation. Abandonment of green energy initiatives and infrastructure projects will eliminate much-needed jobs and community development opportunities and ultimately lead to more droughts and flooding. Cuts to school funding will disproportionately affect the education of Trump supporters' children. One might cynically observe that Trump voters are reaping what they have sown, but in truth, they were the victims of a con job. And no one deserves to be conned. Lawrence KaplanArdsley, N.Y. To the Editor: Re 'Cuts Endanger U.S. Response to Calamities' (front page, July 14): Homeland security officials have been describing the Federal Emergency Management Agency as a bloated dead weight badly in need of reform, but that rhetoric does not match the facts. I was at my desk at FEMA headquarters on the morning of April 19, 1995, when the TV news suddenly announced the terrorist bombing of the Alfred P. Murrah Federal Building in Oklahoma City. Staff members were placed on alert immediately, and within the hour we were receiving our emergency assignments. Mine would be to work the night shift at FEMA's emergency coordination center, helping to monitor and support the rescue efforts. Meanwhile, staff members at FEMA's regional office in Denton, Texas, were already on the phone with Oklahoma state emergency officials. Want all of The Times? Subscribe.


Axios
3 hours ago
- Axios
Medicare, Medicaid to try coverage of GLP-1s for obesity: Report
The Trump administration is reportedly considering a way to ease Medicare and Medicaid into covering GLP-1 drugs like Ozempic and Mounjaro for obesity starting as soon as next year. Why it matters: The Health and Human Services Department in April rejected a Biden administration proposal to allow Medicare and Medicaid to cover the injections for weight-loss. That plan would have cost nearly $40 billion over 10 years. The big picture: The Center for Medicare and Medicaid Innovation is drawing up plans for a five-year experiment in which Medicare prescription drug plans and state Medicaid programs could opt to cover Ozempic, Wegovy, Mounjaro and Zepbound for weight-loss, the Washington Post reported Friday. Wegovy and Zepbound have been approved by the FDA for weight-loss, but many doctors prescribe Ozempic, Mounjaro and other GLP-1 drugs off-label for that purpose. The experiment could start in April 2026 for Medicaid and January 2027 for Medicare plans, per WaPo. "All drug coverages undergo a cost-benefit review. CMS does not comment on potential models or coverage," the agency said in a statement to Axios. Medicare already covers GLP-1s to treat diabetes and heart disease. An October report from congressional scorekeepers found that about half of seniors with obesity are already eligible for GLP-1 coverage to treat other conditions. Insurers have resisted plans for Medicare and Medicaid to expand coverage for the drugs, which can cost more than $1,000 per user per month. HHS Secretary Robert F. Kennedy Jr. panned the use of Ozempic and other GLP-1 drugs for weight-loss before being nominated but has taken a softer stance since then, calling them "miracle drugs" for obesity and diabetes while saying they shouldn't be prescribed without exercise. States already have the option of covering GLP-1s for obesity through Medicaid, though only 13 do.